Literature DB >> 11256683

The use of nimodipine in the treatment of mood disorders.

P J Goodnick1.   

Abstract

Nimodipine, a dihydropyridine calcium entry blocker, has been shown to protect from neuronal damage due to ischemia by providing for increased postischemic perfusion. Further, it has also been demonstrated to have antiepileptic properties. These two properties--calcium channel blockade and anticonvulsant benefits have been applied with success to mood disorder treatment. Although found helpful nearly a decade ago for uncomplicated mania, nimodipine may have particular benefits for those diagnostic subclasses of bipolar disorder most resistant to therapy, e.g., ultra-rapid-cycling bipolars and brief recurrent depressions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256683     DOI: 10.1034/j.1399-5618.2000.020303.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  2 in total

1.  Progesterone blocks multiple routes of ion flux.

Authors:  Brooke G Kelley; Paul G Mermelstein
Journal:  Mol Cell Neurosci       Date:  2011-07-19       Impact factor: 4.314

Review 2.  Rapid cycling bipolar disease: new concepts and treatments.

Authors:  S L Dubovsky
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.